The family of an 11-year-old girl who died two days after having an allergic reaction at school filed a lawsuit against ...

RANCHO CUCAMONGA, CA / ACCESSWIRE / May 22, 2024 / (NASDAQ:AMPH) today announced that the U.S. Food and Drug Administration ...

US-based Amphastar has got FDA nod for Albuterol Sulfate inhalation aerosol, which is the second largest revenue contributor ...

Lupin shares tumbled up to 7%, bogged down by an increased competition in Albuterol Sulfate Inhalation Aerosol in the US.

Purpose: The effects of extreme temperatures on drug delivery of two albuterol sulfate hydrofluoroalkane, metered-dose inhalers (MDIs) were evaluated.Methods. Three Proventil HFA and three ...

Only 14.5 percent of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler ...

The FDA determined that Amphastar's albuterol is bioequivalent and therapeutically equivalent to Teva Respiratory LLC's ProAir® HFA(albuterol sulfate) Inhalation Aerosol. Amphastar's CEO and ...

for albuterol pMDIs producing emissions equivalent to more than 200,000 passenger vehicles. There is an urgent need to develop a low-GWP albuterol pMDI to reduce the environmental impact of the ...

Colin Reisner, CEO of DevPro Biopharma, said, “Albuterol pMDIs account for approximately 45% of all pMDIs used worldwide, contributing substantially to global warming. In the US, about 60 ...

The FDA determined that Amphastar's albuterol is bioequivalent and therapeutically equivalent to Teva Respiratory LLC's ProAir ® HFA (albuterol sulfate) Inhalation Aerosol. Amphastar's CEO and ...